Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Research article

Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies

Authors: Jin Zhang, Guo-dong Chen, Jiang Qiu, Guo-chang Liu, Li-zhong Chen, Kai Fu, Zi-xuan Wu

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

To investigate predictive factors related to graft failure of IgA nephropathy(IgAN) in renal allografts following living donor transplantation.

Methods

We identified a series of 102 biopsies diagnosed as IgAN in renal allografts following living donor transplantation from July 2004 to January 2017 at our center, and assess the predict value of the Lee’s classification and the 2009 Oxford classification in IgAN in renal allografts, clinical, ultrasonic and pathological characteristics at biopsy and the outcomes were retrospectively analyzed.

Results

The 5-year graft cumulative survival rate after transplantation was 91.4%. The 4-year graft cumulative survival rate after biopsy diagnosis of IgAN in renal allografts was 59.6%. The mean time ± SD to disease was 4.7 ± 3.5 years. The color doppler ultrasound and blood flow imagine showed the echo enhancement, the reduced blood flow distribution, the reduced peak systolic velocity of main renal artery, and the increased resistance index of arcuate renal artery were valuable in evaluating the graft dysfunction. The Cox multivariate analysis revealed that the 24-h urinary protein level (HR 1.6 for 1-g increase, 95%CI 1.2–2.0), estimated glomerular filtration rate (eGFR) (HR 1.0 for 1-mL/min/1.73 m^2 decline, 95%CI 1.0–1.1), and mesangial C1q deposition (HR 3.0, 95%CI 1.2–7.4) at biopsy were independent predictive factors of graft failure of IgAN in renal allografts.

Conclusions

IgAN in renal allografts occurred frequently within 5 years after transplantation. The risk of graft failure should be taken seriously in patients who exhibit heavy proteinuria and/or a declined eGFR as the initial symptoms; a high lesion grade (grade IV-V of Lee’s classification) and/or mesangial C1q deposition may also indicated a poor outcome.
Literature
3.
go back to reference El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9(3):527–35.PubMedCrossRef El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9(3):527–35.PubMedCrossRef
4.
go back to reference Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103–9.PubMedCrossRef Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103–9.PubMedCrossRef
5.
go back to reference Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol. 2010;5(12):2363–72.PubMedCrossRef Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol. 2010;5(12):2363–72.PubMedCrossRef
6.
go back to reference McDonald SP, Russ GR. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation. 2006;82(6):759–62.PubMedCrossRef McDonald SP, Russ GR. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation. 2006;82(6):759–62.PubMedCrossRef
7.
go back to reference Moroni G, Longhi S, Quaglini S, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant. 2013;28(5):1305–14.PubMedCrossRef Moroni G, Longhi S, Quaglini S, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant. 2013;28(5):1305–14.PubMedCrossRef
8.
go back to reference Kim SJ, Koo HM, Lim BJ, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One. 2012;7(7):e40495.PubMedPubMedCentralCrossRef Kim SJ, Koo HM, Lim BJ, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One. 2012;7(7):e40495.PubMedPubMedCentralCrossRef
9.
go back to reference Lv J, Shi S, Xu D, et al. Evaluation of the Oxford classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2013;62(5):891–9.PubMedCrossRef Lv J, Shi S, Xu D, et al. Evaluation of the Oxford classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2013;62(5):891–9.PubMedCrossRef
10.
go back to reference Floege J, Gröne HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transplant. 2013;28(5):1070–3.CrossRef Floege J, Gröne HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transplant. 2013;28(5):1070–3.CrossRef
11.
go back to reference Berger J. Recurrence of IgA nephropathy in renal allografts[J]. Am J Kidney Dis. 1988;12(5):371–2.PubMedCrossRef Berger J. Recurrence of IgA nephropathy in renal allografts[J]. Am J Kidney Dis. 1988;12(5):371–2.PubMedCrossRef
12.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(3):S1–155. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(3):S1–155.
13.
go back to reference Kidney disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. 2012;2:139–274.CrossRef Kidney disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. 2012;2:139–274.CrossRef
14.
go back to reference Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl1):S1–266. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl1):S1–266.
16.
go back to reference Nijim S, Vujjini V, Alasfar S, et al. Recurrent IgA nephropathy after kidney transplantation. Transplant Proc. 2016;48(8):2689–94.PubMedCrossRef Nijim S, Vujjini V, Alasfar S, et al. Recurrent IgA nephropathy after kidney transplantation. Transplant Proc. 2016;48(8):2689–94.PubMedCrossRef
17.
go back to reference Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol. 2004;24(3):287–91.PubMedCrossRef Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol. 2004;24(3):287–91.PubMedCrossRef
18.
go back to reference Avasare RS, Rosenstiel PE, Zaky ZS, et al. Predicting post-transplant recurrence of IgA nephropathy: the importance of crescents. Am J Nephrol. 2017;45(2):99–106.PubMedPubMedCentralCrossRef Avasare RS, Rosenstiel PE, Zaky ZS, et al. Predicting post-transplant recurrence of IgA nephropathy: the importance of crescents. Am J Nephrol. 2017;45(2):99–106.PubMedPubMedCentralCrossRef
19.
go back to reference Choy BY, Chan TM, Lo SK, et al. Renal transplantation in patients with primary immunoglobulin a nephropathy. Nephrol Dial Transplant. 2003;18(11):2399–404.CrossRef Choy BY, Chan TM, Lo SK, et al. Renal transplantation in patients with primary immunoglobulin a nephropathy. Nephrol Dial Transplant. 2003;18(11):2399–404.CrossRef
20.
go back to reference Ortiz F, Gelpi R, Koskinen P, et al. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Transplant. 2012;27(6):2553–8.PubMedCrossRef Ortiz F, Gelpi R, Koskinen P, et al. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Transplant. 2012;27(6):2553–8.PubMedCrossRef
21.
go back to reference Radford MG, Donadio JV, Bergstralh EJ, et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8(2):199–207.PubMed Radford MG, Donadio JV, Bergstralh EJ, et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8(2):199–207.PubMed
22.
go back to reference Goto M, Wakai K, Kawamura T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009;24(10):3068–74.PubMedPubMedCentralCrossRef Goto M, Wakai K, Kawamura T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009;24(10):3068–74.PubMedPubMedCentralCrossRef
23.
24.
go back to reference Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study. BMC Nephrol. 2017;18(1):11.PubMedCentralCrossRef Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study. BMC Nephrol. 2017;18(1):11.PubMedCentralCrossRef
25.
go back to reference Platt JF, Rubin JM, Ellis JH. Distinction between obstructive and nonobstructive pyelocaliectasis with duplex Doppler sonography. AJR. 1989;153(5):997–1000.PubMedCrossRef Platt JF, Rubin JM, Ellis JH. Distinction between obstructive and nonobstructive pyelocaliectasis with duplex Doppler sonography. AJR. 1989;153(5):997–1000.PubMedCrossRef
26.
go back to reference Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982;13(4):314–22.CrossRef Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982;13(4):314–22.CrossRef
27.
go back to reference Hisano S, Joh K, Katafuchi R, et al. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, labor and welfare. Clin Exp Nephrol. 2017;21(1):92–6.PubMedCrossRef Hisano S, Joh K, Katafuchi R, et al. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, labor and welfare. Clin Exp Nephrol. 2017;21(1):92–6.PubMedCrossRef
28.
go back to reference Barbour SJ, Espino-Hernandez G, Reich HN, et al. The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int. 2016;89(1):167–75.PubMedCrossRef Barbour SJ, Espino-Hernandez G, Reich HN, et al. The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int. 2016;89(1):167–75.PubMedCrossRef
29.
go back to reference Lee H, Yi SH, Seo MS, et al. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. Korean J Intern Med. 2012;27(3):293–300.PubMedPubMedCentralCrossRef Lee H, Yi SH, Seo MS, et al. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. Korean J Intern Med. 2012;27(3):293–300.PubMedPubMedCentralCrossRef
30.
go back to reference Tanaka S, Ninomiya T, Katafuchi R, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8(12):2082–90.PubMedPubMedCentralCrossRef Tanaka S, Ninomiya T, Katafuchi R, et al. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013;8(12):2082–90.PubMedPubMedCentralCrossRef
31.
go back to reference Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016-the role of crescentic lesions: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014.PubMedCrossRef Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016-the role of crescentic lesions: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014.PubMedCrossRef
32.
go back to reference Lee HJ, Choi SY, Jeong KH, et al. Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol. 2013;80(2):98–104.PubMedCrossRef Lee HJ, Choi SY, Jeong KH, et al. Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol. 2013;80(2):98–104.PubMedCrossRef
33.
go back to reference Nishiwaki H, Hasegawa T, Nagayama Y, et al. Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin a nephropathy. Nephron. 2015;130(1):1–7.PubMedCrossRef Nishiwaki H, Hasegawa T, Nagayama Y, et al. Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin a nephropathy. Nephron. 2015;130(1):1–7.PubMedCrossRef
34.
go back to reference Andrade-Sierra J, Rojas-Campos E, Cardona-Muñoz E, et al. Early steroid withdrawal in recipients of a kidney transplant from a living donor: experience of a single Mexican center. Transplant Proc. 2016;48(1):42–9.CrossRef Andrade-Sierra J, Rojas-Campos E, Cardona-Muñoz E, et al. Early steroid withdrawal in recipients of a kidney transplant from a living donor: experience of a single Mexican center. Transplant Proc. 2016;48(1):42–9.CrossRef
35.
go back to reference Cantarovich D, Rostaing L, Kamar N, et al. Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study. Am J Transplant. 2014;14(11):2556–64.PubMedCrossRef Cantarovich D, Rostaing L, Kamar N, et al. Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study. Am J Transplant. 2014;14(11):2556–64.PubMedCrossRef
36.
go back to reference Ponticelli C, Glassock RJ. IgA nephritis with declining renal function: treatment with corticosteroids may be worthwhile. J Am Soc Nephrol. 2015;26(9):2071–3.PubMedPubMedCentralCrossRef Ponticelli C, Glassock RJ. IgA nephritis with declining renal function: treatment with corticosteroids may be worthwhile. J Am Soc Nephrol. 2015;26(9):2071–3.PubMedPubMedCentralCrossRef
37.
go back to reference Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-termresults of a randomized, controlled trial. J Am Soc Nephrol. 2004;15(1):157–63.PubMedCrossRef Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-termresults of a randomized, controlled trial. J Am Soc Nephrol. 2004;15(1):157–63.PubMedCrossRef
38.
go back to reference Rauen T, Eitner F, Fitzner C, et al. Intensive supportive care plus immunosuppression in IgAnephropathy. N Engl J Med. 2015;373(23):2225–36.PubMedCrossRef Rauen T, Eitner F, Fitzner C, et al. Intensive supportive care plus immunosuppression in IgAnephropathy. N Engl J Med. 2015;373(23):2225–36.PubMedCrossRef
39.
go back to reference Hotta K, Fukasawa Y, Akimoto M, et al. Tonsillectomy ameliorates histological damage of recurrent immunoglobulin a nephropathy after kidney transplantation. Nephrology. 2013;18(12):808–12.CrossRef Hotta K, Fukasawa Y, Akimoto M, et al. Tonsillectomy ameliorates histological damage of recurrent immunoglobulin a nephropathy after kidney transplantation. Nephrology. 2013;18(12):808–12.CrossRef
40.
go back to reference Ushigome H, Suzuki T, Fujiki M, et al. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation. Clin Transpl. 2009;23(S20):17–22.CrossRef Ushigome H, Suzuki T, Fujiki M, et al. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation. Clin Transpl. 2009;23(S20):17–22.CrossRef
Metadata
Title
Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies
Authors
Jin Zhang
Guo-dong Chen
Jiang Qiu
Guo-chang Liu
Li-zhong Chen
Kai Fu
Zi-xuan Wu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1628-z

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue